Virpax Pharmaceuticals Statistics
Total Valuation
VRPX has a market cap or net worth of $4.73 million. The enterprise value is $3.32 million.
Important Dates
The next estimated earnings date is Tuesday, March 25, 2025, before market open.
| Earnings Date | Mar 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VRPX has 26.56 million shares outstanding. The number of shares has increased by 263.24% in one year.
| Current Share Class | 26.56M |
| Shares Outstanding | 26.56M |
| Shares Change (YoY) | +263.24% |
| Shares Change (QoQ) | +98.25% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 0.50% |
| Float | 26.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -5.29 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.63
| Current Ratio | 0.63 |
| Quick Ratio | 0.61 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -116.43 |
Financial Efficiency
Return on equity (ROE) is -2,364.82% and return on invested capital (ROIC) is -1,479.57%.
| Return on Equity (ROE) | -2,364.82% |
| Return on Assets (ROA) | -135.01% |
| Return on Invested Capital (ROIC) | -1,479.57% |
| Return on Capital Employed (ROCE) | 1,322.00% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.72M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.32% in the last 52 weeks. The beta is 0.96, so VRPX's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | -96.32% |
| 50-Day Moving Average | 0.29 |
| 200-Day Moving Average | 0.64 |
| Relative Strength Index (RSI) | 30.87 |
| Average Volume (20 Days) | 14,789,071 |
Short Selling Information
The latest short interest is 1.57 million, so 5.92% of the outstanding shares have been sold short.
| Short Interest | 1.57M |
| Short Previous Month | 631,267 |
| Short % of Shares Out | 5.92% |
| Short % of Float | 5.98% |
| Short Ratio (days to cover) | 1.04 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.08M |
| Pretax Income | -16.89M |
| Net Income | -12.07M |
| EBITDA | n/a |
| EBIT | -12.08M |
| Earnings Per Share (EPS) | -$2.84 |
Full Income StatementBalance Sheet
The company has $1.51 million in cash and n/a in debt, giving a net cash position of $1.51 million or $0.06 per share.
| Cash & Cash Equivalents | 1.51M |
| Total Debt | n/a |
| Net Cash | 1.51M |
| Net Cash Per Share | $0.06 |
| Equity (Book Value) | -913,760 |
| Book Value Per Share | -0.06 |
| Working Capital | -913,760 |
Full Balance SheetCash Flow
| Operating Cash Flow | -16.71M |
| Capital Expenditures | n/a |
| Free Cash Flow | -16.71M |
| FCF Per Share | -$0.63 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |